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ABSTRACT
Skeletal myoblast fusion in vitro requires the expres-
sion of connexin43 (Cx43) gap junction channels.
However, gap junctions are rapidly downregulated
after the initiation of myoblast fusion in vitro and
in vivo. In this study we show that this downregula-
tion is accomplished by two related microRNAs,
miR-206 and miR-1, that inhibit the expression of
Cx43 protein during myoblast differentiation without
altering Cx43 mRNA levels. Cx43 mRNA contains two
binding sites for miR-206/miR-1 in its 30-untranslated
region, both of which are required for efficient
downregulation. While it has been demonstrated
before that miR-1 is involved in myogenesis, in this
work we show that miR-206 is also upregulated
during perinatal skeletal muscle development in
mice in vivo and that both miR-1 and miR-206
downregulate Cx43 expression during myoblast
fusion in vitro. Proper development of singly inner-
vated muscle fibers requires muscle contraction and
NMJ terminal selection and it is hypothesized that
prolonged electrical coupling via gap junctions
may be detrimental to this process. This work details
the mechanism by which initial downregulation of
Cx43 occurs during myogenesis and highlights the
tight control mechanisms that are utilized for the
regulation of gap junctions during differentiation
and development.
INTRODUCTION
Skeletal muscle formation in vertebrates involves an interplay
between the maturation of the contractile and the neural
apparatus which is intricate and interdependent (1–3).
Coordinated events in myogenesis and neuromuscular
junction formation are facilitated by intercellular communica-
tion between myoprogenitors and neurons via signaling
molecules on membrane surfaces as well as between neigh-
boring myoprogenitors and myotubes via gap junctions.
This communication has been repeatedly demonstrated
to be essential for the formation of mature muscle and the
development of a functional neural control mechanism (4–6).
Communication between developing muscle ﬁbers is
extensive during prenatal embryonic development. In fact,
coupling is so extensive prenatally that excitation spreading
laterally between myotubes gives rise to waves of excitation
that propagate across the entire muscle (1). In developing
intercostals muscles, for instance, electrical current applied
to one muscle ﬁber can cause the contraction of the entire
muscle; this depolarization can even spread to neighboring
muscles in the next intercostal space through gap junctional
communication (1). Immediately after birth, gap junctional
communication in skeletal muscle sharply declines. This
downregulation corresponds to the period of retraction of
redundant nerve terminals from muscle ﬁbers. During
myoneural maturation, each stage requires the presence and
contractile activity of functional muscle. Secondary myotube
formation requires innervation, and contractile activity occurs
very early after myotube formation. In utero, contraction of
antagonistic muscles occurs in rhythmic alternation via
reﬂex pathways in the spinal cord (7). Uniﬁed contraction
of embryonic muscle ﬁbers is facilitated by low-resistance
electrical coupling via gap junctions composed primarily of
connexin43 (Cx43). Gap junctions are hypothesized to be
required in embryonic skeletal muscle to allow passage of
signaling molecules and metabolites and for the coordinated
maturation of contractile capabilities (1,8,9). Gap junctional
coupling in hindlimb muscles disappears around birth.
At this time, the only remaining mononuclear cells are the
resident stem cells of skeletal muscle, the satellite cells.
These cells remain quiescent until induced to proliferate
and differentiate in response to injury. Upon injury, Cx43 is
rapidly upregulated and functional gap junction channels
couple proliferating satellite cells in vivo (10). High levels
of Cx43 protein remain until after fusion of myoblasts.
In vivo observations have largely agreed with studies done
on isolated primary myoblast cultures and with myoblast cell
lines. Cx43 is expressed in established myoblast cell lines,
and in isolated primary myoblast cultures prior to fusion
(11,12). The fusion of myoblasts in vitro has been shown
to require the presence of functional gap junctions (4,6,13).
In the presence of heptanol or octanol, known gap junction
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Under these conditions, the myogenic regulatory factors,
myogenin and MRF4, also fail to be upregulated in response
to induction (11). These results of chemical blockade suggest
that functional channels are required for myogenesis in vitro.
Elsewhere, it has been demonstrated that targeted gene
deletion of Cx43, using a Cre-Lox system, inhibits the
regenerative capability of myoblasts in vitro (15) and in vivo.
In myoblast cell lines, Cx43 is present prior to and during
fusion but is rapidly downregulated after induction of differ-
entiation despite only a slight reduction in mRNA levels (6).
These studies suggested that the initial step in downregula-
tion of Cx43 occurs at the translational level. In this study
we present evidence that indicates a role for two microRNAs
in the regulation of Cx43 during myogenesis in mouse
tissues and from cultured myoblasts. This regulation occurs
by inhibiting translation without targeting the message for
degradation. MicroRNAs have been shown to regulate
many other developmental processes. Despite the require-
ment for Cx43 during the initial phase of myogenesis, the
subsequent downregulation of Cx43-dependent gap junc-
tional communication is important in generating insulated
muscle ﬁbers that are singly innervated for ﬁne motor control.
MATERIALS AND METHODS
Bioinformatics
Alignment of DNA sequence pairs was performed using Blast
2 Sequences available at the NCBI website (http://www.ncbi.
nlm.nih.gov/blast/bl2seq/wblast2.cgi) (16). Multiple DNA
sequence alignments were performed using ClustalX v1.8
(17). All genomic, expressed sequence tags (ESTs), and
other nucleotide sequences were obtained from the NCBI
online database via Genomic Blast, Blastn and Unigene,
respectively.
Plasmid construction
Plasmids designed to express full length Cx43 mRNA
sequence were subcloned from cDNA clone B0C01C08
from ATCC into the Xba I and Kpn I sites within
pcDNA3.1 (Invitrogen). Reporter plasmids were constructed
by PCR-amplifying the 30-untranslated region (30-UTR)
from the cDNA clone and inserting the product into
pcDNA3.1 downstream of the ﬁreﬂy luciferase coding region
using the following primer sequences: 50-GATCTCTAGA-
ACAGGCTTGAACATCAAG and 50-GATCGAATTCATT-
ATACTAAATTAAAATTTTATTG. Mutations of miR-206
binding sites were introduced by site-directed mutagenesis
using the following primers: for BS-1 50-CCTACATCC-
CCGCTAAAAAACTAAGCAGTGTTTAAAAACT and 50-
AGTTTTTAAACACTGCTTAGTTTTTTAGCGGGGATGT-
AGG; for BS-2 50-AACTAATTTGTTTGACTAAGCATG-
TTAAACTACTGTCA and 50-TGACAGTAGTTTAACATG-
CTTAGTCAAACAAATTAGTT. The RNA pol III based
expression plasmid, pSUPER, was constructed as described
(18). pSUPER 206pri was constructed by PCR amplifying
a  180 nt region of genomic sequence surrounding pre-
miR-206 and inserting it into pSUPER using the following
primers: 50-CCTACATCCCCGCTAAAAAACTAAGCAGT-
GTTTAAAAACT and 50-AGTTTTTAAACACTGCTTAGT-
TTTTTAGCGGGGATGTAGG. pSUPER miR-1 was con-
structed similarly based on the genomic sequence of the
primary transcript of miR-1-2 with the following primers:
50-CACCAAGCTTTTTGAATTCAGAGTATGGAAGTCATC
and 50-TGATGGATCCCCAAGTAATCCAAATGTCCTAC.
Cell culture
C2C12 cells were a generous gift from Dr Charles Murry at
the University of Washington were cultured as described
(12). HeLa cells were cultured and transfected as described
(19). Luciferase assays were performed as described (19).
Antisense inhibitors of miR-1 and miR-206 as well as nega-
tive control oligonucleotides were purchased from Ambion.
For antisense inhibition of microRNAs, C2C12 cells were
cultured to 50% conﬂuence and transfected with either
100 nM negative control antisense RNA, 100 nM anti-
miR-206, 100 nM anti-miR-1, or 50 nM anti-miR-206 and
50 nM anti-miR-1 for 6 h. Transfections were performed
with Lipofectamine 2000 (Invitrogen) according to the man-
ufacturer’s instructions. Subsequently, the cells were rescued
in differentiation media [DMEM + 5% horse serum (HS) and
ITS] and incubated for 48 h to induce differentiation (12).
RNase protection assay (RPA)
Total RNA was isolated from tissues using Trizol (Invitro-
gen) and a Tekmar homogenizer. Total RNA was isolated
from cell cultures using Trizol. Total RNA from develop-
mental stages of neonatal mice were purchased from Zyagen.
The radiolabeled antisense RNA probe targeting miR-206
was prepared by using the pSUPER 206pri plasmid linearized
with EcoRV as a template with the MaxiScript-T7 in vitro
Transcription Kit (Ambion). RNase protection assays
(RPAs) for miR-206 were performed by using the mirVana
miRNA Detection Kit (Ambion). The antisense RNA probes
against b-actin and Cx43 were performed using the
MaxiScript in vitro Transcription Kit (Ambion) (19). RPAs
targeting b-actin and Cx43 were done by using the RPA
III Kit (Ambion).
Western blots
Total protein extracts from developmental stages of neonatal
mice were purchased from Zyagen. Protein extracts were
prepared in RIPA buffer [1% NP-40, 1% Deoxycholate,
0.1% SDS, 500 mM Tris, 150 mM NaCl, 1 mM PMSF,
1· Protease Inhibitor Cocktail (Roche)]. 10 mg of total
protein was separated on precast 12% Tris–HCl PAGE gels
(BioRad) and electrotransferred to PVDF membranes. Prim-
ary antibodies binding to Cx43 (Sigma, rabbit polyclonal,
1:1000 dilution), myogenin (Sigma, rabbit polyclonal,
1:1000), a-tubulin (Sigma, mouse monoclonal, 1:1000)
were detected with HRP-conjugated anti-rabbit (Sigma) or
HRP-conjugated anti-mouse antibodies (Sigma) and the
ECLplus Western Blotting Detection Kit (Amersham).
Northern blotting
Northern blots designed to detect Cx43, Luciferase and
b-actin mRNA were performed on 20 mg of total RNA
from transfected cells using the NorthernMax Gly Kit
(Ambion). Northern blots designed to detect miR-206 and
5864 Nucleic Acids Research, 2006, Vol. 34, No. 20U6 RNA from transfected HeLa cells were performed on
20 mg of total RNA by separating RNA on precast 15%
TBE 8M urea gels (BioRad). Northern blots designed to detect
U6 RNA from tissue samples utilized 1 mg of total RNA simi-
larly. Fractionated RNA was transferred to positively charged
nylon membrane by electroblotting. The membranes were
blocked in a 1:1 mixture of Ultrahyb:2· SSC, 7% SDS and
probed with 50-biotinylated DNA oligonucleotides [anti-
miR-206 probe (Biotin-CCACACACTTCCTTACATTCCA)
and/or an anti-U6 probe (Biotin-GCTAATCTTCTCTGTAT-
CGTTCCAA)] at a concentration of 10 pM in the same solu-
tion. Biotinylated probe was detected with the BrightStar
Detection Kit (Ambion).
Immunocytochemistry
C2C12 cells cultured in 35 mm dishes (Nunc) were induced
to differentiate by switching to differentiation medium at
 70% conﬂuency. Cells were ﬁxed at various time points
by incubation for 5 min in  10 C methanol and air dryed.
Cells were washed with PBS, further permeabilized for
5 min in 0.1% Triton in PBS and blocked with 5% HS in
PBS for 1 h at room temperature. Cells were incubated
with 1:100 dilution of anti-Cx43 rabbit polyclonal antibody
(Sigma) and 1 mg of anti-myogenin mouse monoclonal
antibody (Sigma) overnight at 4 C in 5% HS in PBS. Dishes
were washed three times in PBS and incubated with 1:100
dilution of goat anti-rabbit-TRITC conjugated secondary
antibody and a 1:100 dilution of goat anti-mouse-FITC
conjugated secondary antibody in PBS with 5% HS. Cells
were washed three times in PBS and incubated for 5 min
with PBS-DAPI. Finally cells were washed three times in
PBS and examined by ﬂuorescence microscopy.
RESULTS
Bioinformatics
Based on evidence from previous work suggesting that
downregulation of Cx43 during myogenesis occurs through
a post-transcriptional mechanism, we looked for the presence
of potential cis elements for translational regulation in
the Cx43 mRNA sequence. Numerous investigators have
published algorithms to detect possible interactions bet-
ween microRNAs and target mRNA sequences. One such
algorithm predicts the presence of two binding sites in the
30-UTR of Cx43 for the microRNA, miR-206 (20). We
aligned the 30-UTR sequences of Cx43 mRNAs from the
domesticated cow, (Bos taurus) (NM174068), the common
dog (Canis familiaris) (NM_001002951 and genomic
sequence from NW876269.1), mouse (Mus musculus)
(NM010288), rat (Rattus norvegicus)(NM012567), chicken
(Gallus gallus)(NM204586 and genomic sequence from
NW060336.1) and human (Homo sapiens)(NM000165)
from Genbank and/or the EST database. The chicken and
dog sequences were did not contain polyadenylation signals
as reported and were extended to conserved polyadenylation
signals downstream (data not shown). These sequences were
conﬁrmed by the presence of overlapping EST sequences.
The ‘seed’ sequence, corresponding to the most important
region for miRNA:mRNA interactions, was completely
conserved in all aligned sequences. The conserved binding
regions are shown in Figure 1.
Tissue distribution of miR-206
To determine the expression pattern of miR-206, RPAs were
performed on 5 mg of total RNA from various tissues. As
shown in Figure 2, miR-206 is expressed predominantly
in adult skeletal muscle; it could also be detected in skin,
E11 whole embryo and lung, but not in heart muscle. The
absence of miR-206 in heart is consistent with the high
levels of Cx43 expression in heart tissue. Conﬁrmation that
miR-206 is indeed expressed in skeletal muscle, but is absent
from cardiac muscle, was important because some published
microarray data had suggested that miR-206 is expressed
in heart, a tissue that expresses high levels of Cx43 (21,22).
A northern blot directed against U6 snRNA demonstrates that
small RNA molecules are represented in each sample.
Downregulation of Cx43 in vitro
In order to test if miR-206 is indeed capable of regulating
Cx43 protein expression in the context of its native mRNA
sequence, we cloned the full-length cDNA corresponding to
the entire Cx43 mRNA sequence from transcription start
site to polyadenylation signal into pcDNA3.1 (pcDNA
Figure 1. Conserved predicted miR-206/miR-1 binding sites in Cx43 30-UTR. Outlined boxes demark the region that is perfectly complimentary to miR-206/
miR-1 and is most important for microRNA:mRNA interaction (28). This region is 2 nt larger than the ‘seed’ region used by Lewis et al. (25) to find potential
miR-206/miR-1 targets.
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contained a  180 nt genomic insert under control of the
H1 RNA promoter (pSUPER 206pri) (18). For expression
studies, the human cervical cancer cell line HeLa was used
because it expresses neither Cx43 nor miR-206. HeLa cells
were grown in culture and transfected with pcDNA Cx43
and either pSUPER 206pri or pSUPER as a negative control.
Forty-eight hours after transfection, protein extracts and total
RNA were prepared. Western blot analysis against Cx43
shows a signiﬁcant inhibition of Cx43 expression as shown
in Figure 3A. A control western blot against a-tubulin
showed that this protein remained unchanged. Northern blot
analysis against total RNA revealed that the presence of
miR-206 did not affect the level of Cx43 mRNA. As
expected, miR-206 was only present when the cells were
transfected with pSUPER 206pri. As a control for the
efﬁciency of small RNA puriﬁcation, the blot was stripped
and rehybridized with a probe against U6 snRNA. Data
from three independent experiments yielded a reproducible
and considerable inhibition of Cx43 expression by miR-
206. This experiment unequivocally shows that Cx43 can
be regulated at the post-transcriptional level by miR-206
and further supports the hypothesis that miR-206 is responsi-
ble for the initial downregulation of Cx43 during myogenesis.
To test the speciﬁc regulation of Cx43 through the two
predicted binding sites, we inserted the Cx43 30-UTR
sequence downstream of the ﬁreﬂy luciferase coding region.
Mutants of the putative binding sites were then prepared
(Figure 3B). Known sequence similarity between miR-206
and miR-1 caused us to also consider miR-1 as a potential
regulator of Cx43 despite the suggestions that miR-1 and
Cx43 coexist in cardiac tissue. Therefore, a plasmid desig-
ned to deliver miR-1 utilizing the pSUPER vector was
constructed for comparison. As shown in this ﬁgure, there
is less complimentarity between miR-1 and binding site 1
than between miR-206 and the same sequence. As expected,
the wild-type 30-UTR (pcDNA Luc 43-30-UTR) construct was
signiﬁcantly inhibited by the presence of miR-206 and to
a lesser degree by miR-1 (Figure 3C). Mutating either one
of the binding sites alone had a partial effect on the ability
of miR-206 to inhibit the expression of the luciferase reporter
but completely abolished the ability of miR-1 to regulate
luciferase expression. A double mutant completely abolished
the inhibitory effect of miR-206 on the reporter expression.
There was no statistically signiﬁcant effect of combining
miR-1 and miR-206 in this experimental model, sugges-
ting that there is no synergistic or additive effect of the
microRNAs when they are overexpressed together. In another
series of experiments, two other non-related microRNAs,
miR-183 and miR-137, were compared to miR-206 tested
for their effect on luciferase expression. These microRNAs
(also produced from pSUPER based plasmids) produced no
signiﬁcant difference in luciferase expression when compared
to the empty vector (data not shown).
Regulation of Cx43 during development
Since we determined that miR-206 and to a lesser extent
miR-1 are capable of regulating Cx43 expression through
direct binding to the 30-UTR of its mRNA and that miR-
206 is expressed in skeletal muscle, the next step was to
look in vivo to see if miR-206 regulates Cx43 expression
during myogenesis. We predicted that miR-206 RNA and
Cx43 protein levels should be inversely related in a manner
consistent with muscle development. To this end, we
performed an RPA on total RNA isolated from skeletal
muscle derived from 2 days prenatal mice (E16), and the
ﬁrst, third, and ﬁfth days after birth. At 2 days prenatal,
miR-206 became visible reaching a maximum level by day
3 postnatal (Figure 4). Western blots for Cx43 protein show
that its levels decrease signiﬁcantly after birth. In contrast,
Cx43 mRNA levels remains unchanged during this period,
as determined by RPA. The observed downregulation of
Cx43 during this time period is in agreement with previous
reports that have shown that myoblasts and developing
myotubes express high levels of Cx43 gap junctions prior
to and during fusion and growth (8,11). A high level of
expression of miR-206 during myogenesis in vivo supports
the notion that this miRNA is involved in the downregulation
of connexin during perinatal development, the time when the
bulk of skeletal muscle is being formed. It has been shown
elsewhere that miR-1 shows a similar pattern of upregulation
during in neonatal mouse muscle (23).
Downregulation of Cx43 in C2C12 cells
To conﬁrm and extend our hypothesis that miR-206 plays
an inportanat role in muscle cell development, we studied
the expression of miR-206 in myoblasts in vitro, using
a highly myogenic subclone of the mouse cell line C2C12.
These cells are propagated as undifferentiated, mononucle-
ated myoblasts under high serum conditions. When cultures
are switched to low serum, they rapidly fuse into contractile
myotubes. It has been reported that Cx43 is highly expressed
in the mononucleated C2C12 myoblasts but is rapidly down-
regulated after induction of differentiation. C2C12 cells are
often used to recapitulate the muscle differentiation pathway
in vitro. To conﬁrm the pattern of Cx43 expression in this
in vitro model for muscle development, C2C12 cells were
cultured to  70% conﬂuency in growth media and then
induced to differentiate by switching to differentiation
medium. Samples were ﬁxed at day 0 (day of induction)
and every 24 h until day 3. Immunoﬂuorescence studies
were performed to detect Cx43 protein and myogenin, a
marker for differentiation in skeletal muscle. As shown in
Figure 5, Cx43 was highly expressed in proliferating
myoblasts at time 0. As expected, Cx43 protein is localized
at the nuclear periphery, where it is synthesized on the
endoplasmic reticulum and processed in the Golgi apparatus.
 
Figure 2. Tissue distribution of miR-206. RNase protection assay to detect
miR-206 was performed on 5 mg of total RNA from various tissue samples.
5 mg of total RNA was subjected to RPA. 1 mg of total RNA was used to
detect U6 snRNA by northern blotting.
5866 Nucleic Acids Research, 2006, Vol. 34, No. 20Figure 3. Regulation of Cx43 by miR-206/1 in vitro.( A) HeLa cells were mock transfected or transfected with cDNA for Cx43 in addition to empty pSUPER
plasmid or pSUPER 206pri. After 48 h Western blots and RNA analysis was performed as described in the Materials and Methods section. (B) Diagram of
luciferase reporter construct with putative miR-206 binding sites and mutations. Binding sites were mutated in pcDNA Luc 43-30-UTR and the 50-UTR was
individually cloned into each mutant to make the constructs containing both the 50- and 30-UTRs. (C) Effect of binding site mutants on luciferase expression in
the presence of miR-206, miR-1 or both miR-206 and miR-1. HeLa cells were transfected with pcDNA Luc constructs along with either pSUPER or pSUPER
206pri and analysed 24 h later. Data is presented as relative firefly luciferase units (RLUs). Relative firefly luciferase values were determined by a ratio of firefly
to renilla luciferase with the negative control set at 1. Error bars—standard deviation; 0 > 9. *A student’s t-test performed between microRNA transfected
samples and the negative control yielded a P-value < 0.05 (actual P-value < 0.01).
Nucleic Acids Research, 2006, Vol. 34, No. 20 5867It can also be seen at punctuate loci at cellular borders.
Myogenin was undetectable at this time. After 1 day of
differentiation, high levels of Cx43 were still located in the
nuclear periphery and at regions of cellular apposition.
Myogenin, the muscle-speciﬁc basic helix-loop-helix tran-
scription factor, began to be expressed and was located in
the nucleus as evidenced by its co-localization with the
nuclear stain DAPI. At day 1 there were still no detectable
multinucleated cells.
By day 2, expression of Cx43 had become undetectable in
the perinuclear region and between cells, whereas myogenin
expression had increased signiﬁcantly. At this time, there
were some multinucleated myotubes and some mononucle-
ated myoblasts, none of which expressed Cx43. At day 3,
most of the mononucleated cells had disappeared, there was
no detectable Cx43 and myogenin was very highly expressed
in all nuclei. These results indicate that C2C12 differen-
tiation recapitulates the Cx43 regulatory pathway seen in
developing skeletal muscle and should be a good model for
dissecting the mechanism of Cx43 downregulation.
In order to further validate the in vivo correlations, we
investigated the expression of Cx43 protein and mRNA as
well as miR-206 during C2C12 myoblast differentiation.
These cells were cultured in growth media and then
induced to differentiate. Extracts were prepared at the
time of induction and every 24 h thereafter. As shown in
Figure 6A, Cx43 was highly expressed in proliferating
myoblasts and continued its high levels of expression through
day 1 of differentiation. At this time there was little expres-
sion of miR-206. By day 2 of differentiation there was a
drastic reduction in the levels of Cx43 protein, and this
level remained low until day 5, at which point Cx43 was
undetectable. Expression of miR-206 was ﬁrst clearly
detectable on day 2 and came to a plateau around day 4.
This is similar to the study by Chen et al. which showed
that miR-1 expression was ﬁrst detectible on day 3 post
induction (23). The control northern blot to detect U6 showed
that puriﬁcation of the small RNA fraction of total RNA
was consistent. The level of Cx43 mRNA was unchanged
Figure 4. miR-206 regulates Cx43 during myoblast fusion and skeletal
muscle development. Total RNA and total lysates were isolated from skeletal
muscle from Swiss-Webster mice at E16 ( 2days), day 1, 3, or 5 after birth.
RNase protection assay was performed against miR-206 (500 ng total RNA)
or Cx43 mRNA and b-actin (10 mg total RNA). Western blots were
performed on 10 mg total protein as described in the Materials and Methods
section.
Figure 5. Connexin43 is downregulated during myoblast differentiation. Arrows denote positive immunostaining for Cx43 at membrane appositions. Cells were
incubated with 1:100 dilution of anti-connexin43 rabbit polyclonal antibody (Sigma) and 1 mg of anti-myogenin mouse monoclonal antibody (Sigma) overnight
at 4 C in 5% HS in PBS. Dishes were examined by fluorescence and phase contrast microscopy using FITC, rhodamine and DAPI filters.
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tion of Cx43 protein occurred post-transcriptionally. Levels
of b-actin mRNA remained unchanged throughout the experi-
ment and served as an internal control. In fact, extended
experiments have shown that Cx43 mRNA levels were lar-
gely unchanged through 12 days of differentiation in
C2C12 cells (data not shown). Myogenin, the marker for
myoblast differentiation, was not detectable in proliferating
C2C12 cells but was rapidly upregulated in response to the
medium change.
Finally, to show that miR-206 and miR-1 are indeed
responsible for the downregulation of Cx43 in C2C12 cells,
the cells were transfected with chemically modiﬁed antisense
oligonucleotide microRNA inhibitors either individually or in
combination immediately prior to induction of differentiation.
Extracts were harvested 48 h after induction and levels of
Cx43 were measured. At 2 days of differentiation, there
was signiﬁcant cell fusion in all experimental conditions.
There was no observable difference in cell number, morphol-
ogy or gross myotube size (data not shown). Prior to differen-
tiation, Cx43 was highly expressed as shown in Figure 6B.
After 48 h, the C2C12 cells transfected with a negative
control oligonucleotide showed signiﬁcant downregula-
tion of Cx43. In addition, cells transfected with either
anti-miR-1 or anti-miR-206 RNA alone still downregulated
Cx43 expression. However, cells transfected with both anti-
miR-1 and anti-miR-206 RNA demonstrated a high level
of Cx43 expression, similar to the levels seen in
undifferentiated cells.
DISCUSSION
Skeletal muscle development in vertebrates is an evolutionar-
ily conserved process that involves myoblast fusion into
multinucleated myotubes. Prior to and during myoblast
fusion, and during the development of the motor neuron
input system, muscle precursors are electrically coupled via
gap junctions. In mammals, as well as in zebraﬁsh, frogs
and chickens, Cx43 is downregulated during late embryoge-
nesis and early post-natal life. Conservation of the Cx43
expression pattern suggests the existence of a conservation
of mechanism. The work presented here demonstrates the
role of two related microRNAs in the downregulation of
Cx43 during differentiation of skeletal muscle.
The prediction that miR-206 and to a lesser degree miR-1
would bind to the Cx43 mRNA by Lewis et al. (20) was one
of many computer algorithms that predicted that a microRNA
binding site was present in the Cx43 30-UTR. Others, such as
the DIANA MicroT algorithm, predict the binding of other
microRNAs (24). These sites, however, are not conserved
between species making them unlikely candidates to be
involved in a conserved developmental mechanism. We,
therefore, focused this study on the miR-206/miR-1 interac-
tion with Cx43. An alignment of the 30-UTR of Cx43
mRNAs from mouse, rat, human, dog, cow and chicken
shows complete conservation of the ‘seed’ region of the
miRNA:mRNA target interaction for both predicted targets
(see Figure 1). This region corresponds to the 50 end of the
microRNA sequence and generally consists of 6–8 consecu-
tive Watson–Crick base pairs with the mRNA target. The
seed region has been repeatedly demonstrated to be important
for target recognition by an miRNA (20,25–28). The conser-
vation of these sequences increases the likelihood that Cx43
is indeed regulated by miR-206/miR-1, particularly since
the overall rate of 30-UTR sequence identity between these
species is  36% (data not shown).
Data presented in Figure 3 show that miR-206 expression
from pSUPER 206pri is capable of inhibiting the expression
of a luciferase reporter bearing the 30-UTR of Cx43. This
experiment demonstrates that even with overexpression of
both components of the system, the microRNA is capable
of reducing luciferase expression despite the fact that the
mRNA levels are not signiﬁcantly affected (data not
shown). As shown in Figure 3A, miR-206 inhibits the
expression of Cx43 protein signiﬁcantly as compared to the
empty pSUPER control. From the results shown in
Figure 3B and C, one can conclude that miR-206 binds to
the Cx43 30-UTR through two independent binding sites,
and that it is this binding that mediates its ability to inhibit
the translation of the Cx43 message. It is also shown that
miR-1 is capable of regulating Cx43, albeit to a lesser degree,
by virtue of its inability to regulate expression when
either binding site is mutated alone. The results provided in
Figure 3 present compelling evidence that miR-206, and pos-
sibly miR-1, have the potential to regulate Cx43 expression.
Figure 6. (A) C2C12 cells were grown in growth medium and induced to
differentiate at  70% confluency by switching to DMEM supplemented with
5% HS and 1· ITS. Cells were harvested prior to induction (t ¼ 0) and at 24 h
intervals thereafter. miR-206 was detected by RNase protection assay on 1 mg
of total RNA. Cx43 mRNA and b-actin mRNA were detected by RNase
protection assay on 10 mg of total RNA. Western blots against Cx43,
myogenin and a-tubulin were performed on 10 mg of total protein. (B) C2C12
cells were grown in growth medium and induced to differentiate at  50%
confluency by switching to DMEM supplemented with 5% HS and 1· ITS.
Cells were harvested prior to induction (t ¼ 0) or transfected with negative
control microRNA inhibitor, anti-miR-206, anti-miR-1 or anti-miR-206 and
anti-miR-1 and induced to differentiate. Transfected cells were harvested 48 h
later. Western blots against Cx43 and a-tubulin were performed on 10 mg
of total protein.
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the myogenic process in vitro has provided a convenient
method to study associated developmental processes. In
C2C12 cells, myotubes begin to appear at day 2 of differen-
tiation, concurrent with the decline in Cx43 levels. Cx43
protein levels become undetectable by day 5 of culture in
differentiation medium. The downregulation of Cx43 protein
is coincident with the upregulation of miR-206 which begins
before day 2. The levels of Cx43 mRNA remain unchanged
during the course of this experiment, consistent with the
hypothesis that microRNAs are indeed responsible for the
post-transcriptional inhibition of Cx43 expression. Further
conﬁrmation that miR-206 and miR-1 regulate Cx43
expression comes from the inactivation of these microRNAs
by antisense RNA during C2C12 maturation. As shown in
Figure 6, both microRNAs must be inactivated for Cx43
expression to remain at its undifferentiated levels. Although
there is a near total recovery of Cx43 levels in those cells
transfected with anti-miR-1 and anti-miR-206 together, the
magnitude of decrease in Cx43 levels during differentia-
tion seen in Figure 6B was less than what was seen in
Figure 6A. This is most likely due to the difference in experi-
mental methods between the two experiments. In Figure 6A,
the cells were induced to differentiate at 70% conﬂuence
whereas in the antisense inhibition experiment the cells
were transfected and induced to differentiate at only 50%
conﬂuence. This difference in methodology was necessary
because of the recommended lower optimal cell density for
tranfection (Lipofectamine 2000, Invitrogen). It is also
possible that there is a generalized effect of transfection
with small RNA molecules on the downregulation of Cx43
by miR-206/1 in these cells or a generalized inhibition of
differentiation by the liposome-mediated transfection pro-
cess. The differentiation of C2C12 cells in culture is highly
dependent on cell–cell contact and cell density; notably,
these cells were subcloned to be highly myogenic (12). The
ﬁnding that Cx43 protein expression during myoblast
differentiation is inversely correlated with expression of
miR-206 along with the ﬁnding that the inhibition of
miR-206 and its family member miR-1 relieve this down-
regulation, suggests that miR-206 and miR-1 perform
redundant or additive functions in regulating Cx43 in
C2C12 cells. This correlates with the ﬁnding that miR-206
is capable of downregulating Cx43 protein expressed from
full-length Cx43 mRNA expressed in HeLa cells, and
luciferase expression that bears Cx43 30-UTR sequences. It
cannot, however, be entirely ruled out that the increase in
Cx43 expression at day 2 in the presence of anti-miR-1 and
anti-miR-206 together is due to an inhibitory effect on
myoblast differentiation that was previously described but
not seen by these experimental methods (23). This correla-
tion must be further studied in vivo in developing skeletal
muscle in order to further delineate the timing and quantita-
tive levels of each microRNA during mouse development.
A number of publications have implicated miR-1 in the
regulation of skeletal muscle differentiation in both verte-
brates and invertebrates as well as during cardiogenesis in
vertebrates (23,29,30). Our observation that miR-1 down-
regulates Cx43 during C2C12 differentiation was somewhat
surprising because of the previous reports that both Cx43
and miR-1 are present in adult cardiac tissue. Further studies
are required to investigate whether miR-1 and Cx43 actually
are coexpressed within cardiomyocytes in the adult and
whether miR-1 plays a role in regulating Cx43 in the
developing and/or adult heart.
The observation that Cx43 levels decrease during mamma-
lian perinatal skeletal muscle development was ﬁrst seen
decades ago (1,2,9,11,14,31,32). Data from only one group
have suggested that the downregulation may occur at the
post-transcriptional level, although this possibility was not
pursued in their work (11). In whole skeletal muscle extracts,
isolated 2 days prior to birth (E16), Cx43 protein is highly
expressed (Figure 4). This is in agreement with previous
reports that primary and secondary myotubes, as well as
undifferentiated myoblasts, are highly coupled before birth
(9). In contrast, on the day of birth and thereafter, Cx43
expression is barely detectable whereas levels of miR-206
are greatly increased. Cx43 mRNA levels are not signiﬁcantly
altered during this period. Maximum levels of miR-206 occur
around day 3 after birth and are  4-fold higher than adult
levels (data not shown). Other reports have demonstrated
that miR-1 is expressed in a similar manner during develop-
ment. A quantitative comparison of miR-206 and miR-1
levels was beyond the scope of this publication.
The miR-206 gene is located between the polycystic
kidney and hepatic disease 1 gene and the interleukin-17
gene in mouse (chr 1), rat (chr 9) and human (chr 6). The
genomic site where the pre-miR-206 sequence is located
contains another microRNA precursor sequence, miR-133b,
located a mere  3.8 kb downstream, suggesting that miR-
206 and miR-133b might be part of the same primary
transcript (33). Microarray data published by other laborator-
ies have shown that miR-133b, like miR-206, is expres-
sed in skeletal muscle (21,22). Apparent tissue-speciﬁc
co-expression of miR-206 and miR-133b supports the idea
that they may be produced from the same primary transcript.
In fact a novel noncoding RNA, 7H4, has been isolated and
shown to be enriched in sub-synaptic nuclei of innervated
muscle (34). This RNA corresponds to the genomic locations
of both pre-miR-206 and pre-miR-133b. This suggests a
possible correlation between NMJ maturation and speciﬁc
microRNA expression. During the preparation of this manu-
script, Rao et al. (35) published data demonstrating the
upregulation of miR-1, miR-133 and miR-206 in C2C12
cells during differentiation. However, these authors identiﬁed
no targets for miR-206, and there was no mention of redun-
dancy or cooperation between these two microRNAs during
muscle development. There has been one study which was
able to show that a mutation in the 30-UTR of the myostatin
gene creates a cryptic microRNA binding site for miR-1/
miR-206. This mutation was responsible for creating a
phenotype that included hypertrophic skeletal muscle (36).
Additional recent studies have demonstrated regulatory
pathways responsible for the expression of miR-206 during
embryonic development (35,37). This work and the work
of others have demonstrated an early expression pattern
associated with somites in chicken and mouse embryos and
with developing muscle in zebraﬁsh (24,38,39). Recently,
another microRNA, miR-181 has been shown to be required
for efﬁcient myoblast differentiation by regulating Hox-A11
(40). Clearly there are multiple microRNAs that play a role
in skeletal muscle development and this tissue system will
5870 Nucleic Acids Research, 2006, Vol. 34, No. 20provide fertile ground to study the regulatory networks
involved in differentiation.
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